Lunit's AI Solutions Strengthen Qatar's National Breast Cancer Screening Program

AI For Business


Runit CI logo
  • Middle Eastern The first major deployment of AI in nationwide screening marks Runit's latest milestone as global cancer screening efforts rapidly expand.

Seoul, South Korea, July 22, 2024 Germany, May 23, 2020 /PRNewswire/ — Lunit, a leading provider of AI-powered solutions for cancer diagnosis and treatment, today announced that it has launched its AI-powered breast cancer detection solution, Lunit INSIGHT MMG, in China. Qatari National Breast Cancer Screening Program: This will be the first nationwide implementation of AI into breast cancer screening workflows at a national level. middle eastThe partnership has an initial term of five years, demonstrating a long-term commitment to promoting breast cancer screening. Qatar.

Lunit uses Lunit INSIGHT MMG "Screen for Life" Qatar Primary Health Care Corporation (PHCC) Program
Lunit has successfully integrated Lunit INSIGHT MMG into Qatar Primary Healthcare Corporation's (PHCC) “Screen for Life” program.

boot June 2024, Qatari The Primary Healthcare Corporation (PHCC) has integrated Runit Insight MMG into its Screen for Life program, a national breast and colorectal cancer screening initiative. The AI ​​solution aims to enhance early detection of breast cancer, reduce missed diagnoses and improve survival rates. Qatari A screening program every three years.

“Breast cancer is the most common cancer among women. QatarAccounts for 32% of cancer cases in women[1]” said the doctor. Sheikha Abu Sheikha“To address this issue, we are deploying Lunit's AI as a critical second opinion for radiologists,” said Dr. David G. Schneider, Early Detection Program Director at PHCC. middle east To implement AI across our screening programs, we Qatari A commitment to providing quality health care to women across the nation.”

This implementation follows a successful retrospective validation phase that began in 2010. March 2023Satisfied with the performance and added value, two radiologists now refer to the Lunit INSIGHT MMG results while reading each mammogram, improving the accuracy and efficiency of the screening process.

Runit's success Qatar This is part of the company's broader trend of expanding its business-to-government (B2G) cancer screening initiatives around the world. Recent notable deployments include:

  • Australia: Supplying Lunit INSIGHT MMG to Breastscreen New South Wales
  • Sweden: Capio St. Gautier Hospital receives Lunit INSIGHT MMG, marking the first time AI has replaced one human reader in breast cancer screening.
  • Kingdom of Saudi Arabia: Providing Lunit INSIGHT suite to Seha Virtual Hospital, connecting over 150 hospitals
  • Iceland: Lunit INSIGHT MMG introduced for national breast cancer screening, first European country to introduce AI to entire population

“Collaboration with us Qatari “The PHCC for Screen for Life provides healthcare providers with a powerful new tool to enhance medical diagnostics,” said Brandon Hsu“As we roll out national screening programs around the world, we are enhancing early cancer detection and revolutionizing preventive healthcare. With each implementation, we get closer to our vision of making AI-assisted cancer screening more accurate and available to people around the world, anywhere,” said Lunit CEO, Lunit.

The Screen for Life program is Qatari PHCC is a national initiative that provides free breast and colorectal cancer screening to eligible residents. Qatari Public health strategies aim to promote early detection through education, awareness and accessible testing services.

About Runit

Founded in 2013, Lunit is a medical AI company with a mission to defeat cancer. We leverage AI-powered medical image analysis and AI biomarkers to ensure accurate diagnosis and optimal treatment for each cancer patient. Our FDA-approved Lunit INSIGHT suite for cancer screening is available to over 3,000 hospitals and healthcare institutions in over 40 countries.

Our clinical research results have been published in top journals such as the Journal of Clinical Oncology and Lancet Digital Health and presented at global congresses such as ASCO and RSNA.

In 2024, Lunit acquired Volpara Health Technologies, creating a foundation for unmatched synergy and accuracy specifically in breast health and screening technology.

Head Office Location Seoul, South KoreaWith offices around the world, Runit is leading the global effort to end cancer. Learn more here. Runit.

sauce Runit's AI Solutions Strengthen Qatar's National Breast Cancer Screening Program

The information provided in this article was created by Cision PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of Thailand Business News.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *